secwatch.observer — SEC 8-K summary
======================================

Issuer:     Editas Medicine, Inc. (EDIT)
CIK:        0001650664
Form:       8-K
Filed at:   2026-04-07T23:59:59+00:00
Accession:  0001650664-26-000030
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Editas Medicine dismisses EY, appoints PwC as independent auditor for FY2026
----------------------------------------------------------------------------

- Audit Committee dismissed EY effective April 1, 2026; EY notified on April 2, 2026.
- PwC appointed as new independent registered public accounting firm for FY ending Dec 31, 2026.
- No disagreements or reportable events with EY during FY2024, FY2025, or interim period.
- EY's letter to SEC filed as Exhibit 16.1, agreeing with the disclosure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1650664/000165066426000030/0001650664-26-000030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1650664/000165066426000030/edit-20260401.htm
  HTML page:      https://secwatch.observer/filing/0001650664-26-000030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer